Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 15, 2000

View Archived Issues

Oxford Glyco Intends To Raise $215M As It Gains Nasdaq Listing

MediGene Filling Pipeline With U.S.-Based NeuroVir Acquisition

ReNeuron Raises #19.5M In IPO To Fund Stem Cell Technologies

Japan Tobacco Opening London Office To Increase EU Partnering

Wellcome Trust Increasing Spending To #600M Per Year

Lion, Celera Strengthen Their Collaboration In Bioinformatics

French Officials Still Not Ready To Adopt EU Biotech Directive

Merged German Firm Cardion Gains Strong Stem Cell Position

Other News To Note

GenOdyssee, UroGhne Enter Deal On Prostate Cancer SNPs

Parliament, Ministers Find Some Consensus On Directive Update

EU Commissioners Express Support For Biotech Direction

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...